Abstract
44103 Ruxolitinib Cream Monotherapy Use Demonstrates Maintenance of Disease and Symptom Control With Use As Needed in Adults and Adolescents With Atopic Dermatitis: Pooled Analysis From the Long Term Safety Periods of Two Phase 3 Studies
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have